Cutaneous mosaic RASopathies associated with rhabdomyosarcoma

Area of Science:

• Oncology
• Genetics
• Pediatric Cancer Research

Background:

• RAS gene variants are established drivers of various pediatric cancers, including brain tumors.
• Germline RAS variants are associated with a slightly elevated risk of rhabdomyosarcoma (RMS).
• The role of somatic RAS variants in sporadic RMS development is less understood.

Purpose of the Study:

• To investigate the association between specific somatic RAS variants and an increased risk of rhabdomyosarcoma (RMS).
• To explore the potential link between RAS-driven birthmarks and the development of RMS.
• To highlight the need for further research and potential monitoring guidelines for at-risk pediatric patients.

Main Methods:

• Case study analysis of three new pediatric rhabdomyosarcoma (RMS) cases.
• Comprehensive literature review on RAS variants and RMS.
• Clinical observation of concomitant RAS-driven birthmarks in affected individuals.

Main Results:

• Identified rare instances where somatic RAS variants are linked to an increased risk of RMS.
• Observed that RMS development may be preceded by the presence of RAS-driven birthmarks.
• Demonstrated a potential, albeit rare, association between specific RAS variants and RMS.

Conclusions:

• Certain somatic RAS variants represent a rare risk factor for pediatric rhabdomyosarcoma (RMS).
• The presence of RAS-driven birthmarks may serve as a potential indicator for RMS risk.
• Prospective studies are essential to determine incidence and establish monitoring guidelines for at-risk children.